PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 7:33 AM ET

Sponsor Check › Person

DW
No photo found yet (own website and image search run after this page is viewed)

David G. Wang

Named as an officer, director or promoter on SEC Form D filings · China (as filed: F4), NY · Feb 27, 2017 → Oct 16, 2026

7deals (issuers)
$2.99Breported sold
386investors
21Form D filings
2017–2026years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:32 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

David G. Wang is listed as an executive officer and director on 21 SEC Form D filings by 7 issuers between Feb 2017 and Oct 2026. Largest by amount reported sold: OrbiMed Asia Partners VI, L.P. (New York, NY — pooled investment fund — 2025–2026; $1.05B reported sold to 72 investors), OrbiMed Asia Partners V, L.P. (New York, NY — pooled investment fund — 2022; $651.9M reported sold to 68 investors), OrbiMed Asia Partners III, L.P. (New York, NY — pooled investment fund — 2017; $540M reported sold to 97 investors), OrbiMed Asia Partners IV, L.P. (New York, NY — pooled investment fund — 2020; $486.9M reported sold to 86 investors), Power Innovation Fund, L.P. (New York, NY — pooled investment fund — 2020–2026; $179.8M reported sold to 56 investors) and 2 more (all listed below).

What this means A repeat sponsor — 7 separate companies raised money with this person listed as executive officer and director, over about 9 years. Across those companies the filings report $2.99B sold in total.

Listed alongside Carl L. Gordon (12 shared filings), Sunny Sharma (11 shared filings), W. Carter Neild (11 shared filings), Power Innovation GP, LLC (9 shared filings, management entity), Sven H. Borho (9 shared filings) and 16 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around David. Each name links to their own page.

The issuers belong to 2 sponsor groups: Orbimed (37 issuers, $20.2B reported sold, 2009–2026) and Power Innovation (2 issuers, $212.9M reported sold, 2020–2026).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 2 court cases matching the name, 14 bankruptcy cases matching the name listed in Key records below.

What this means 16 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 21 public filings for David G. Wang and found 18 differences, 3 worth asking the sponsor about: Bankruptcy case: David Wang; Paid seller listed without a CRD number: UBS Switzerland AG; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for David G. Wang has not run yet — it is joining a line of 23,723 names; searches run around the clock at the hosts' allowed rate. Searched so far: 638 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

2 cases: 2 closed (disposition not in docket feed)

David Wang v. Foot Locker Retail, Inc. closed
District Court, C.D. California · No. 2:19-cv-07385 · Filed Aug 26, 2019 · Closed Oct 21, 2019 · Nature of suit: P.I.: Other · Cause: 28:1441 Notice of Removal
Role of David Wang: Plaintiff · Outcome: Terminated 2019-10-21 — FJC Integrated Database disposition: Remanded to state court Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); 15 people with this name in Form D filings; court in CA (not a filing state)
Directv Inc v. David Wang closed
District Court, C.D. California · No. 2:03-cv-08692 · Filed Nov 28, 2003 · Closed Jul 1, 2004
Role of David Wang: Defendant · Outcome: Terminated 2004-07-01 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); 15 people with this name in Form D filings; court in CA (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:32 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: VA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched David G. Wang..

State securities regulators: Securities regulators searched (3,318 actions): AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE DOJ Investor Protection Unit (257 actions, 1987–2026), TX State Securities Board (586 actions, 2006–2026), WA DFI (2,039 actions, 2001–2026) — last crawled Oct 23, 2026, 9:57 PM ET. No machine-readable public listing today for CO, FL, IA, IN, MN, NE, NJ, NY, OH, UT, VA (see docs/state-regulators.md).

3. Bankruptcies

14 cases: 14 closed (disposition not in docket feed)

David H Wang closed
United States Bankruptcy Court, E.D. Texas · No. 17-42372 · Filed Oct 31, 2017 · Closed Mar 29, 2018
Role of David H Wang: Debtor · Outcome: Case closed 2018-03-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); 15 people with this name in Form D filings; court in TX (not a filing state); middle initial differs
David Wang and Allie Shivers-Wang closed
United States Bankruptcy Court, N.D. Illinois · No. 17-12259 · Filed Apr 19, 2017 · Closed Aug 10, 2017
Role of David Wang and Allie Shivers-Wang: Debtor · Outcome: Case closed 2017-08-10 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); 15 people with this name in Form D filings; court in IL (not a filing state); middle initial differs
Yu Huang and David Wang closed
United States Bankruptcy Court, E.D. New York · No. 1-13-43773 · Filed Jun 20, 2013 · Closed Sep 19, 2013
Role of Yu Huang and David Wang: Debtor · Outcome: Case closed 2013-09-19 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); 15 people with this name in Form D filings; court in the person's filing state (NY); middle initial differs
David C Wang and Tina Wang closed
United States Bankruptcy Court, C.D. California · No. 2:10-bk-33168 · Filed Jun 8, 2010 · Closed Jan 6, 2011
Role of David C Wang and Tina Wang: Debtor · Outcome: Case closed 2011-01-06 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); 15 people with this name in Form D filings; court in CA (not a filing state); middle initial differs
David Wang and Pauline Wang closed
United States Bankruptcy Court, C.D. California · No. 6:10-bk-19850 · Filed Apr 2, 2010 · Closed Aug 11, 2010
Role of David Wang and Pauline Wang: Debtor · Outcome: Case closed 2010-08-11 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); 15 people with this name in Form D filings; court in CA (not a filing state); middle initial differs
David D W Wang and Grace H M Wang closed
United States Bankruptcy Court, E.D. New York · No. 8-09-78135 · Filed Oct 27, 2009 · Closed Feb 24, 2010
Role of David D W Wang and Grace H M Wang: Debtor · Outcome: Case closed 2010-02-24 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); 15 people with this name in Form D filings; court in the person's filing state (NY); middle initial differs
David Wang closed
United States Bankruptcy Court, C.D. California · No. 2:01-bk-32374 · Filed Jul 23, 2001 · Closed Apr 11, 2002
Role of David Wang: Debtor · Outcome: Case closed 2002-04-11 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); 15 people with this name in Form D filings; court in CA (not a filing state)
David Wang closed
United States Bankruptcy Court, C.D. California · No. 2:01-bk-24275 · Filed May 8, 2001 · Closed Jun 29, 2001
Role of David Wang: Debtor · Outcome: Case closed 2001-06-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); 15 people with this name in Form D filings; court in CA (not a filing state)
David Wang closed
United States Bankruptcy Court, E.D. New York · No. 1-99-18501 · Filed Jun 24, 1999 · Closed Oct 19, 1999
Role of David Wang: Debtor · Outcome: Case closed 1999-10-19 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); 15 people with this name in Form D filings; court in the person's filing state (NY)
David W Wang closed
United States Bankruptcy Court, C.D. California · No. 1:96-bk-19580 · Filed Aug 22, 1996 · Closed Dec 19, 1996
Role of David W Wang: Debtor · Outcome: Case closed 1996-12-19 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); 15 people with this name in Form D filings; court in CA (not a filing state); middle initial differs
David P. Wang closed
United States Bankruptcy Court, N.D. Ohio · No. 95-11287 · Filed Mar 24, 1995 · Closed Sep 19, 1995
Role of David P. Wang: Debtor · Outcome: Case closed 1995-09-19 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); 15 people with this name in Form D filings; court in OH (not a filing state); middle initial differs
David P. Wang closed
United States Bankruptcy Court, N.D. Ohio · No. 94-13023 · Filed Jul 18, 1994 · Closed Feb 23, 1995
Role of David P. Wang: Debtor · Outcome: Case closed 1995-02-23 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); 15 people with this name in Form D filings; court in OH (not a filing state); middle initial differs
David T. Wang closed
United States Bankruptcy Court, D. Massachusetts · No. 92-14968 · Filed May 15, 1992 · Closed Oct 2, 1992
Role of David T. Wang: Debtor · Outcome: Case closed 1992-10-02 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); 15 people with this name in Form D filings; court in MA (not a filing state); middle initial differs
David J Wang and Jennifer Wang closed
United States Bankruptcy Court, N.D. Illinois · No. 92-07490 · Filed Mar 31, 1992 · Closed Apr 29, 1998
Role of David J Wang and Jennifer Wang: Debtor · Outcome: Case closed 1998-04-29 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 23 federal dockets); 15 people with this name in Form D filings; court in IL (not a filing state); middle initial differs
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:32 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

18 differences found between the filings for David G. Wang — 3 worth asking about (compared 21 filings on Oct 24, 2026)

Worth asking · Jun 24, 1999 – Oct 19, 1999

Bankruptcy case: David Wang — filed Jun 24, 1999

United States Bankruptcy Court, E.D. New York docket "David Wang" filed Jun 24, 1999, closed Oct 19, 1999. David G. Wang is listed as Debtor ("David Wang"). Our match estimate: 44%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Sources
Note · Oct 13, 2010 – Jun 5, 2012

Bankruptcy case: Megan Dow — filed Oct 13, 2010

United States Bankruptcy Court, N.D. New York docket "Megan Dow" filed Oct 13, 2010, closed Jun 5, 2012. Megan Dow (listed on the same filings) is listed as Debtor ("Megan Dow"). Our match estimate: 70%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Sources
Worth asking · Sep 29, 2025 – Oct 16, 2026

Paid seller listed without a CRD number: UBS Switzerland AG — OrbiMed Asia Partners VI, L.P.

UBS Switzerland AG is listed as receiving sales compensation on 3 filings (Sep 29, 2025 to Oct 16, 2026) with no FINRA CRD number given.

What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.

Sources
Worth asking · Feb 15, 2024 – Mar 10, 2025

Form D filed 389 days after the first sale — Avalon Electricity Fund

The filing says the first sale was Feb 15, 2024. The Form D was filed Mar 10, 2025 — 389 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 374 days past that.

What this means The notice went in months after money was taken in. Late notices are common and carry no penalty by themselves, but it is fair to ask the sponsor why the paperwork lagged.

Sources
Note · Jul 8, 2024 – Jul 17, 2024

No amendment in the last 12 months on an offering that may still be open — Belenos Biosciences, Inc. (latest filing Jul 17, 2024)

The latest filing for this offering is dated Jul 17, 2024 (first sale Jul 8, 2024). It reports $48,000,000 sold of $55,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Apr 29, 2022 – Nov 28, 2022

No amendment in the last 12 months on an offering that may still be open — OrbiMed Asia Partners V, L.P. (latest filing Nov 28, 2022)

The latest filing for this offering is dated Nov 28, 2022 (first sale Apr 29, 2022). It reports $651,872,014 sold of $1,100,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Mar 6, 2020 – Sep 2, 2020

No amendment in the last 12 months on an offering that may still be open — OrbiMed Asia Partners IV, L.P. (latest filing Sep 2, 2020)

The latest filing for this offering is dated Sep 2, 2020 (first sale Mar 6, 2020). It reports $486,882,011 sold of $750,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Mar 1, 2017 – Jun 28, 2017

David G. Wang's role changed at OrbiMed Asia Partners III, L.P.: executive officer → director

The Mar 1, 2017 filing lists David G. Wang as executive officer; the Jun 28, 2017 Form D/A lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Sources
Note · May 28, 2026 – Oct 16, 2026

Offering amount changed between filings — OrbiMed Asia Partners VI, L.P.

The May 28, 2026 filing says $850,000,000 offered; the Oct 16, 2026 Form D/A says $1,045,599,648.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Jun 28, 2017 – Sep 6, 2017

Offering amount changed between filings — OrbiMed Asia Partners III, L.P.

The Jun 28, 2017 filing says $450,000,000 offered; the Sep 6, 2017 Form D/A says $539,960,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Sources
Note · Jun 28, 2017 – Sep 6, 2017

Minimum investment changed between filings — OrbiMed Asia Partners III, L.P.

The Jun 28, 2017 filing lists a minimum of $0; the Sep 6, 2017 Form D/A lists $100,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Sources
Note · Feb 27, 2017 – Mar 31, 2020

David G. Wang is written 2 different ways on the filings

listed as "David G. Wang" on 11 filings (from Feb 27, 2017), and "David Wang" on 10 filings (from Mar 31, 2020).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Sources
Note · Sep 7, 2010 – Jun 25, 2026

Same name, different state: "David Wang" (CA) is a separate record

This page covers filings where the address state is F4 or NY. A separate record, "David Wang" with address state CA, is listed on 27 filings — most recently by TCW Steel City Senior Lending BDC (Jun 25, 2026). Both records have filings in the same period (Feb 27, 2017 to Jun 25, 2026).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Sep 15, 2022 – Jun 4, 2026

Same name, different state: "David Wang" (CO) is a separate record

This page covers filings where the address state is F4 or NY. A separate record, "David Wang" with address state CO, is listed on 3 filings — most recently by BioIntelliSense, Inc. (Jun 4, 2026). Both records have filings in the same period (Sep 15, 2022 to Jun 4, 2026).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Oct 15, 2013 – Sep 22, 2021

Same name, different state: "David Wang" (A1) is a separate record

This page covers filings where the address state is F4 or NY. A separate record, "David Wang" with address state A1, is listed on 2 filings — most recently by BioVaxys Technology Corp. (Sep 22, 2021). Both records have filings in the same period (Feb 27, 2017 to Sep 22, 2021).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Mar 31, 2017

Same name, different state: "David Wang" (E9) is a separate record

This page covers filings where the address state is F4 or NY. A separate record, "David Wang" with address state E9, is listed on 1 filing — most recently by WestSummit Global Technology Fund III, L.P. (Mar 31, 2017). Both records have filings in the same period (Mar 31, 2017).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Mar 2, 2016

Same name, different state: "DAVID WANG" (NC) is a separate record

This page covers filings where the address state is F4 or NY. A separate record, "DAVID WANG" with address state NC, is listed on 1 filing — most recently by KONOST INC. (Mar 2, 2016). The two records do not overlap in time: this page runs Feb 27, 2017 to Oct 16, 2026; the other has one filing dated Mar 2, 2016.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Feb 27, 2017 – Oct 16, 2026

David G. Wang is listed with 2 different address states: F4, NY

China (as filed: F4) on 11 filings (Feb 27, 2017 to Oct 16, 2026); NY on 10 filings (Mar 31, 2020 to Mar 4, 2026).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

1 of 7 offerings reports sales commissions totalling $2,478,300; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Oct 16, 2026 D/A
OrbiMed Asia Partners VI, L.P.
File 021-559156
$0 (est.)$0 (est.)$0 (est.)
An affiliate of the GPLP will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the active investment period and a percentage tied to invested capital thereafter.
UBS Switzerland AG no CRD number reported
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED BrokerCheck CRD 7691 ↗
J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗
EDGAR ↗
Mar 4, 2026 D/A
Avalon Electricity Fund
File 021-540313
$0$0$0 (est.)
Power Innovation GP, LLC, sub-advisors, and certain persons listed in Item 3 may receive a management fee or other advisory fees based on the value of the issuer's assets and/or a performance-based fee based on the issuer's profits.
None listed on this filingEDGAR ↗
Mar 2, 2026 D/A
Power Innovation Fund, L.P.
File 021-364014
$0 (est.)$0 (est.)$0 (est.)
Power Innovation GP, LLC and certain persons listed in Item 3 may receive a management fee based on the value of the issuer's assets and/or a performance-based fee based on the issuer's profits.
None listed on this filingEDGAR ↗
Jul 17, 2024 D
Belenos Biosciences, Inc.
File 021-519049
$0$0$0None listed on this filingEDGAR ↗
Nov 28, 2022 D/A
OrbiMed Asia Partners V, L.P.
File 021-443753
$0 (est.)$0 (est.)$0 (est.)
An affiliate of the GPLP and GPLTD will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage of invested capital thereafter.
J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗
Wells Fargo Clearing Services, LLC BrokerCheck CRD 19616 ↗
Wells Fargo Advisors Financial Network, LLC BrokerCheck CRD 11025 ↗
EDGAR ↗
Sep 2, 2020 D/A
OrbiMed Asia Partners IV, L.P.
File 021-362067
$0 (est.)$0 (est.)$0 (est.)
An affiliate of the GPLP and GPLTD will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage of invested capital thereafter.
J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗EDGAR ↗
Sep 6, 2017 D/A
OrbiMed Asia Partners III, L.P.
File 021-281414
$2,478,300$0$0 (est.)
An affiliate of the GPLP will receive a fee for management services. The fee will equal a percentage of aggregate subscriptions of the Issuer's limited partners during the investment period and a percentage based on invested capital thereafter.
J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗EDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 7

Every issuer that named David G. Wang on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Pooled Investment Fund · group: Orbimed

OrbiMed Asia Partners VI, L.P.

New York, NY · Sep 29, 2025 → Oct 16, 2026 · 3 filings
  • Oct 16, 2026 · D/A · $1,045,599,648 sold of $1,045,599,648 · 72 investors · min. No minimum reported · role: Director (Director of the GPLTD) EDGAR ↗
  • May 28, 2026 · D/A · $533,984,000 sold of $850,000,000 · 45 investors · min. No minimum reported · role: Director (Director of the GPLTD) EDGAR ↗
  • Sep 29, 2025 · D · $0 sold of $850,000,000 · 0 investors · min. No minimum reported · role: Director (Director of the GPLTD) EDGAR ↗

Raised $1.05B from 72 investors (100% of the $1.05B target) as of the latest filing. David is listed as director on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Power Innovation

Avalon Electricity Fund

New York, NY · Mar 10, 2025 → Mar 4, 2026 · 2 filings
  • Mar 4, 2026 · D/A · $33,128,775 sold of Indefinite · 5 investors · min. No minimum reported · role: Director (Managing Member of the General Partner) EDGAR ↗
  • Mar 10, 2025 · D · $25,635,305 sold of Indefinite · 5 investors · min. No minimum reported · role: Director (Managing Member of the General Partner) EDGAR ↗

Raised $33.1M from 5 investors as of the latest filing. David is listed as director on 2 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Power Innovation

Power Innovation Fund, L.P.

New York, NY · Mar 31, 2020 → Mar 2, 2026 · 7 filings
  • Mar 2, 2026 · D/A · $179,762,711 sold of Indefinite · 56 investors · min. No minimum reported · role: Executive Officer (Managing Member of the GP of the Issuer and Managing Principal of the IM of the Issuer) EDGAR ↗
  • Mar 3, 2025 · D/A · $151,458,961 sold of Indefinite · 56 investors · min. No minimum reported · role: Executive Officer (Managing Member of the GP of the Issuer and Managing Principal of the IM of the Issuer) EDGAR ↗
  • Feb 29, 2024 · D/A · $145,543,560 sold of Indefinite · 53 investors · min. No minimum reported · role: Executive Officer (Managing Member of the GP of the Issuer and Managing Principal of the IM of the Issuer) EDGAR ↗
  • Mar 13, 2023 · D/A · $93,740,031 sold of Indefinite · 51 investors · min. No minimum reported · role: Executive Officer (Managing Member of the GP of the Issuer and Managing Principal of the IM of the Issuer) EDGAR ↗
  • Mar 15, 2022 · D/A · $50,014,500 sold of Indefinite · 38 investors · min. No minimum reported · role: Executive Officer (Managing Member of the GP of the Issuer and Managing Principal of the IM of the Issuer.) EDGAR ↗
  • Mar 29, 2021 · D/A · $35,134,500 sold of Indefinite · 22 investors · min. No minimum reported · role: Executive Officer (Managing Member of the GP of the Issuer and Managing Principal of the IM of the Issuer.) EDGAR ↗
  • Mar 31, 2020 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer (Managing Member of the GP of the Issuer and Managing Principal of the IM of the Issuer.) EDGAR ↗

Raised $179.8M from 56 investors as of the latest filing. David is listed as executive officer on 7 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other · group: Orbimed

Belenos Biosciences, Inc.

New York, NY · Jul 17, 2024
  • Jul 17, 2024 · D · $48,000,000 sold of $55,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $48M from 2 investors (87% of the $55M target) as of the latest filing. David is listed as director.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Orbimed

OrbiMed Asia Partners V, L.P.

New York, NY · Apr 28, 2022 → Nov 28, 2022 · 2 filings
  • Nov 28, 2022 · D/A · $651,872,014 sold of $1,100,000,000 · 68 investors · min. No minimum reported · role: Director (Director of the GPLTD) EDGAR ↗
  • Apr 28, 2022 · D · $0 sold of $1,100,000,000 · 0 investors · min. No minimum reported · role: Director (Director of the GPLTD) EDGAR ↗

Raised $651.9M from 68 investors (59% of the $1.1B target) as of the latest filing. David is listed as director on 2 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Orbimed

OrbiMed Asia Partners IV, L.P.

New York, NY · Mar 5, 2020 → Sep 2, 2020 · 2 filings
  • Sep 2, 2020 · D/A · $486,882,011 sold of $750,000,000 · 86 investors · min. No minimum reported · role: Director (Director of the GPLTD) EDGAR ↗
  • Mar 5, 2020 · D · $0 sold of $750,000,000 · 0 investors · min. No minimum reported · role: Director (Director of the GPLTD) EDGAR ↗

Raised $486.9M from 86 investors (65% of the $750M target) as of the latest filing. David is listed as director on 2 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Pooled Investment Fund · group: Orbimed

OrbiMed Asia Partners III, L.P.

New York, NY · Feb 27, 2017 → Sep 6, 2017 · 4 filings
  • Sep 6, 2017 · D/A · $539,960,000 sold of $539,960,000 · 97 investors · min. $100,000 · role: Director (Director of the GPLTD) EDGAR ↗
  • Jun 28, 2017 · D/A · $431,530,000 sold of $450,000,000 · 95 investors · min. No minimum reported · role: Director (Director of the GPLTD) EDGAR ↗
  • Mar 1, 2017 · D/A · $0 sold of $450,000,000 · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Feb 27, 2017 · D · $0 sold of $450,000,000 · 0 investors · min. No minimum reported · role: Executive Officer EDGAR ↗

Raised $540M from 97 investors (100% of the $540M target) as of the latest filing. David is listed as director, executive officer on 4 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (14)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • David Wang — CA, 17 issuers, Sep 7, 2010 → Jun 25, 2026 · no shared issuer
  • David Wang — British Columbia, Canada (as filed: A1), 2 issuers, Oct 15, 2013 → Sep 22, 2021 · no shared issuer
  • David Wang — FL, 2 issuers, Apr 12, 2022 → Apr 12, 2022 · no shared issuer
  • David Wang — CO, 1 issuer, Sep 15, 2022 → Jun 4, 2026 · no shared issuer
  • David S.C. Wang — Hong Kong (as filed: K3), 1 issuer, May 26, 2011 → May 26, 2011 · no shared issuer
  • DAVID WANG — NC, 1 issuer, Mar 2, 2016 → Mar 2, 2016 · no shared issuer
  • David Wang — Cayman Islands (as filed: E9), 1 issuer, Mar 31, 2017 → Mar 31, 2017 · no shared issuer
  • David Wang — MI, 1 issuer, Feb 28, 2017 → Jan 15, 2020 · no shared issuer
  • David Wang — NJ, 1 issuer, Dec 15, 2020 → Dec 15, 2020 · no shared issuer
  • David Wang — KY, 1 issuer, Jan 12, 2021 → Jan 12, 2021 · no shared issuer
  • DAVID WANG — WA, 1 issuer, Jun 21, 2021 → Jun 21, 2021 · no shared issuer
  • David Wang — DE, 1 issuer, Jun 8, 2022 → Jun 8, 2022 · no shared issuer
  • David Wang — China (as filed: F4), 1 issuer, Oct 22, 2014 → Oct 22, 2014 · no shared issuer
  • David T.K. Wang — CA, 1 issuer, Sep 1, 2016 → Sep 1, 2016 · no shared issuer

People around David 21

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

Management entity

Power Innovation GP, LLC

Executive Officer · 9 shared filings (2 issuers)

Listed on the same filings as David G. Wang. Their page shows their other deals.

Management entity

Power Innovation Partners, L.P.

Executive Officer · 7 shared filings (1 issuer)

Listed on the same filings as David G. Wang. Their page shows their other deals.

Management entity

OrbiMed Asia GP III, L.P.

Executive Officer, Promoter · 4 shared filings (1 issuer)

Listed on the same filings as David G. Wang. Their page shows their other deals.

Management entity

OrbiMed Advisors III Limited

Executive Officer, Promoter · 4 shared filings (1 issuer)

Listed on the same filings as David G. Wang. Their page shows their other deals.

Management entity

OrbiMed Asia GP VI, L.P.

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as David G. Wang. Their page shows their other deals.

Management entity

OrbiMed Advisors VI Limited

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as David G. Wang. Their page shows their other deals.

Management entity

OrbiMed Asia GP IV, L.P.

Executive Officer, Promoter · 2 shared filings (1 issuer)

Listed on the same filings as David G. Wang. Their page shows their other deals.

Management entity

OrbiMed Advisors IV Limited

Executive Officer, Promoter · 2 shared filings (1 issuer)

Listed on the same filings as David G. Wang. Their page shows their other deals.

Management entity

OrbiMed Asia GP V, L.P.

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as David G. Wang. Their page shows their other deals.

Management entity

OrbiMed Advisors V Limited

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as David G. Wang. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Carl L. Gordon

Director · 12 shared filings (5 issuers) · also on 57 other issuers

Carl L. Gordon is on 62 issuers in total — a repeat sponsor. Their page lists every one.

WN
No photo found yet (own website and image search run after this page is viewed)
Person

W. Carter Neild

Director · 11 shared filings (4 issuers) · also on 21 other issuers

W. Carter Neild is on 25 issuers in total — a repeat sponsor. Their page lists every one.

SS
No photo found yet (own website and image search run after this page is viewed)
Person

Sunny Sharma

Executive Officer, Director · 11 shared filings (4 issuers)

Listed on the same filings as David G. Wang. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Sven H. Borho

Executive Officer, Director · 9 shared filings (4 issuers) · also on 23 other issuers

Sven H. Borho is on 27 issuers in total — a repeat sponsor. Their page lists every one.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Jonathan T. Silverstein

Director · 6 shared filings (2 issuers) · also on 31 other issuers

Jonathan T. Silverstein is on 33 issuers in total — a repeat sponsor. Their page lists every one.

SI
No photo found yet (own website and image search run after this page is viewed)
Person

Samuel D. Isaly

Promoter, Director · 4 shared filings (1 issuer) · also on 18 other issuers

Samuel D. Isaly is on 19 issuers in total — a repeat sponsor. Their page lists every one.

JW
No photo found yet (own website and image search run after this page is viewed)
Person

Jonathan Wang

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as David G. Wang. Their page shows their other deals.

BC
No photo found yet (own website and image search run after this page is viewed)
Person

Bo Chen

Director · 1 shared filing (1 issuer)

Listed on the same filings as David G. Wang. Their page shows their other deals.

TD
No photo found yet (own website and image search run after this page is viewed)
Person

Tania Dimitrova

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as David G. Wang. Their page shows their other deals.

MD
No photo found yet (own website and image search run after this page is viewed)
Person

Megan Dow

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as David G. Wang. Their page shows their other deals.

SM
No photo found yet (own website and image search run after this page is viewed)
Person

StJohn Donnie McGrath

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as David G. Wang. Their page shows their other deals.

The team behind the deals

Sponsor group

Orbimed

37 issuers · 166 filings · $20.2B reported sold · 2009–2026

One team, 37 deal companies. David G. Wang is listed on 5 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name David G. Wang.

Sponsor group

Power Innovation

2 issuers · 9 filings · $212.9M reported sold · 2020–2026

One team, 2 deal companies. David G. Wang is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name David G. Wang.

Same business address

18 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

A person is never an adviser firm. 1 of the 7 issuers this person is listed on matches a Form ADV adviser (searched 24,962 advisers as of Oct 2, 2026): Power Innovation Fund, L.P..

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to David G. Wang by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 7 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers David G. Wang is listed on: none on file. No website or social profile named in Belenos Biosciences, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #94,546 of 374,652 in line (1,194 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (New York, NY). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when David G. Wang appears on a new Form D, or when a court case or SEC action is matched to them. See plans →